Income Statement
MONOPAR THERAPEUTICS
MNPR
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY |
|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | 0.00 | 0.00 | 0.00 |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - | - | - | - |
|
Operating Expenses
|
16.70 | 16.16 | 8.83 | 10.54 | 9.13 | 6.51 | 4.32 | 3.40 | 16.60 |
|
Research & Development
|
9.90 | 13.01 | 5.60 | 7.59 | 6.49 | 4.07 | 1.97 | 1.77 | 0.94 |
|
Selling, General & Administrative
|
6.80 | 3.16 | 3.23 | 2.95 | 2.63 | 2.44 | 2.36 | 1.63 | 1.17 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - |
|
Operating Income
|
-16.70 | -16.16 | -8.83 | -10.54 | -9.13 | -6.51 | -4.32 | -3.40 | -16.60 |
|
Non-Operating Income
|
- | - | - | - | - | - | - | -0.10 | - |
|
Interest Income
|
2.99 | 0.40 | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
-13.72 | -15.59 | - | - | - | - | - | -3.30 | - |
|
Income Tax Expense
|
- | - | - | - | - | - | - | -0.07 | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - |
|
Net Income
|
-13.72 | -15.59 | -8.40 | -10.52 | 0.00 | 6.30 | -4.22 | -3.23 | -16.55 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY |
|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - |
|
EBITDA
|
-16.70 | -16.16 | -8.83 | -10.54 | -9.13 | -6.51 | -4.32 | -3.40 | -16.60 |
|
Earnings Per Share (Basic)
|
-1.85 | -4.11 | -0.61 | - | - | - | - | - | - |
|
Diluted EPS
|
- | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
7.41 | 3.79 | 13.82 | 12.72 | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
- | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
-13.62 | -15.54 | -8.43 | -10.50 | -9.10 | -6.30 | -4.23 | -3.23 | - |